Learn · Research area

Metabolic & Incretin

Semaglutide, tirzepatide and retatrutide: the GLP-1, GIP and glucagon receptor agonists that reshaped obesity and diabetes research — how they differ, what the trials showed, and what remains open.

Guides & how-tos

Peptide profiles

1 research profile in Metabolic & Incretin, listed alphabetically.

Compound Research area Overview Read the profile
GLP-1 & Incretin Peptides The incretin system and the GLP series decoded — semaglutide, tirzepatide, and retatrutide. Decodes the GLP series — semaglutide (GLP-1-S), tirzepatide (GLP-2-T), retatrutide (GLP-3-R) — and explains single, dual, and triple incretin receptor agonism, with real Phase 3 trials. Read →

← All Learn articles